Zinzino group revenue increased with a total of 3%, compared with the previous year.
STOCKHOLM, June 7, 2022 /PRNewswire/ -- The revenue in May for Zinzino's sales markets increased by 1% and amounted to SEK 106.0 (104.5) million. Faun Pharma's external sales increased by 47% and amounted to SEK 6.6 (4.5) million. Overall, the Group increased revenues by 3% to SEK 112.6 (109.0) million compared with the previous year.
Accumulated revenue for January May 2022 were unchanged compared with the same period last year and amounted to SEK 548.0 (549.0) million.
Revenues were distributed as follows:
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:30 the 7th of June 2022.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2022,c3581367
The following files are available for download: